Clinical Trials Logo
  1. Home
  2. Metastatic Liver Cancer
  3. NCT02201797

Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Metastatic Liver Cancer Clinical Trial

Official title:
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Clinical Trial Summary

Advanced MRI (Magnetic Resonance Imaging) technique called DCE (Dynamic Contrast Enhanced) and DWI MRI can provide valuable information regarding tumor biology and response to treatment through various parameters. Validating stability of these parameters will further establish robustness and reliability of these promising biomarkers.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02201797
Study type Interventional
Source Asan Medical Center
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date June 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT04970212 - Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
Recruiting NCT04616495 - Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases
Terminated NCT03349255 - Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma Phase 1
Recruiting NCT03965546 - ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer Early Phase 1
Terminated NCT03998033 - Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Phase 1
Not yet recruiting NCT04825470 - Liver Transplantation for Unresectable GIST Liver Metastases N/A
Recruiting NCT04864054 - T-Cell Therapy (ECT204) in Adults With Advanced HCC Phase 2
Recruiting NCT05913141 - PDO/PDO-TIL/PDOTS for Drug Screen
Not yet recruiting NCT05582018 - Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures N/A
Recruiting NCT01895010 - Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE Phase 2
Withdrawn NCT05641922 - Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2) N/A
Recruiting NCT04634357 - ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma Phase 1/Phase 2
Recruiting NCT04708483 - DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria N/A
Terminated NCT02787954 - Prospective Tumor Response Evaluation
Completed NCT04513457 - Chemotherapy for Resectable Colorectal Liver Metastases
Recruiting NCT01442324 - Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma N/A
Completed NCT03888859 - ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma Early Phase 1
Not yet recruiting NCT05643417 - Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy Phase 1
Recruiting NCT05240950 - Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases Phase 1
Not yet recruiting NCT05986383 - Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree